Posts Tagged ‘Zepatier’

By REUTERSJAN. 29, 2016 United States regulators on Thursday approved a new once-daily pill for the liver-destroying hepatitis C virus made by Merck, which said it would sell the drug at a lower list price than its competitors. The list price for Zepatier will be $54,600 for a 12-week regimen, which Merck said it expected…